Dentsply Sirona CAO gets phantom stock grant

Czerney Kevin reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Czerney Kevin reported acquisition or exercise transactions in this Form 4 filing.

DENTSPLY SIRONA Inc. reported that VP and Chief Accounting Officer Kevin Czerney received a grant of 2,853.551 shares of phantom stock under the company’s Supplemental Executive Retirement Plan. Each phantom share is economically equivalent to one common share and becomes payable in common stock when his employment ends.

Following this award, Czerney holds a total of 6,346.9846 phantom stock shares directly, all tied to the company’s common stock and described as a SERP contribution for 2025 based on the 12/31/25 closing price.

Insider Trade Summary

Grant/Award: 2,853.551 shares

Grant/Award 1 txn

Insider Czerney Kevin

Role VP, Chief Accounting Officer

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock (Supplemental Executive Retirement Plan) SERP	2,853.551	$11.43	$33K

Holdings After Transaction: Phantom Stock (Supplemental Executive Retirement Plan) SERP — 6,346.9846 contracts (Direct)

Footnotes (3)

1. F1. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of employment.
2. F2. Comprised of phantom stock.
3. F3. Supplemental Executive Retirement Plan (SERP) contribution for the year 2025 based on 12/31/25 closing price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did DENTSPLY SIRONA (XRAY) executive Kevin Czerney report on this Form 4?

Kevin Czerney reported receiving 2,853.551 phantom stock shares tied to DENTSPLY SIRONA common stock. The award was made under the Supplemental Executive Retirement Plan and increases his total phantom stock holdings to 6,346.9846 shares.

How large is Kevin Czerney’s new phantom stock grant at DENTSPLY SIRONA (XRAY)?

The grant totals 2,853.551 phantom stock shares, each economically equivalent to one share of common stock. This award is part of a Supplemental Executive Retirement Plan contribution and reflects compensation rather than an open-market stock purchase.

What is phantom stock in the DENTSPLY SIRONA (XRAY) Form 4 filing?

The filing states that each phantom stock share is economically equivalent to one common share. These phantom shares become payable in common stock upon the reporting person’s termination of employment, functioning as deferred, share-linked compensation.

How many phantom stock shares does Kevin Czerney hold after this DENTSPLY SIRONA (XRAY) transaction?

After the transaction, Czerney directly holds 6,346.9846 phantom stock shares. All are linked to DENTSPLY SIRONA common stock and are described as being comprised of phantom stock units under the company’s Supplemental Executive Retirement Plan.

What period does the new phantom stock contribution for DENTSPLY SIRONA (XRAY) cover?

The filing notes that the award is a Supplemental Executive Retirement Plan contribution for the year 2025. It is based on the closing price of DENTSPLY SIRONA common stock on December 31, 2025, according to the disclosure footnote.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/12/2026 - 05:38 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Czerney Kevin

(Last) (First) (Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE NC 28277

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP, Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock (Supplemental Executive Retirement Plan) SERP	(1)	03/11/2026		A		2,853.551(2)		(1)	(1)	Common Stock	2,853.551	$11.43(3)	6,346.9846	D

Explanation of Responses:

1. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of employment.

2. Comprised of phantom stock.

3. Supplemental Executive Retirement Plan (SERP) contribution for the year 2025 based on 12/31/25 closing price.

	/s/ Jessica Nielsen Causey, Attorney-In-Fact for Kevin Czerney	03/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.